An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
VY1706 first in human study in early Alzheimer\'s Disease is a multicenter dose escalation study
Epistemonikos ID: 85ece2b59e8fd89f3cadd7597418a03d997489bf
First added on: Aug 14, 2026